How to future-proof your serialization and track-and-trace strategy with standardized solutions

Based on a fully configurable and centralized architecture at site level, Adents Pharma Suite integrates easily with existing infrastructure and equipment, deploys quickly, and can easily manage all regulation requirements pertaining to drug serialization and aggregation.

Paris (France) – Adents, the French unit identification and traceability software editor will contribute to LogiPharma, the largest global end-to-end supply chain event for pharma supply chain leaders taking place from 19th to 21th April 2016 at Montreux Music & Convention Centre, Switzerland .

Through interactive discussions and debates, learn practical solutions to optimise your supply chain value, visibility, flexibility and deliver a customer-first experience whilst saving costs, reducing risk, and remaining compliant.

Julien Boisnet, Senior Sales Director, Europe, Adents will host the round-table discussion « How to future-proof your serialization and track-and-trace strategy with standardized solutions? » on Wednesday 20 April 2016 at 3.05pm

How can you meet global serialization regulatory requirements easily within deadlines?
What are the keys to manage multi-phase implementation and achieve compliance long term?
How to join the dots between your batch records & your serialization/aggregation data ?

Currently in charge of sales development on the European market for Adents, Julien Boisnet has a track record of more than 12 years as sales executive, representative and management for engineering and software companies.

Speed to deployment, with an implementation of up to 5x faster than the competition
Fewer qualification tests needed on high speed packaging lines, resulting in optimized productivity –
Standardized solution that meets the pharmaceutical industry’s highest quality standards (GMP, 21 CFR Part 11 and GAMP5 guidelines)
Improved cost effectiveness with a competitive yearly license including service

LATEST PRESS RELEASES

COVID-19: Adents' Business Continuity plan

The COVID-19 coronavirus epidemic has already affected thousands of people around the world and we expect the French government to announce stricter containment measures soon. Since Adents employees are mainly based in France and the United States, we take the health and economic risks linked to this epidemic very seriously.

13-Mar
2020

Laboratoires Théa addresses European FMD and South Korea market regulation requirements with Adents Cloud serialization solution

Leading Ophtalmic Pharmaceuticals Company chose Adents Prodigi to connect with approximately 15 supply chain partners to stay compliant with current and future regulations.

24-Jun
2019

Pharmascience Chooses Software from Adents to Ensure European FMD and US DSCSA Serialization Compliance Regulations

Pharmascience,the 4th largest manufacturer of over-the-counter and generic drugs in Canada, has chosen to partner with Adents, a leading provider of versatile and easily deployable serialization and track-and-trace software solutions, to assure compliance with the European Falsified Medicines Directive as well as the U.S. DSCSA serialization regulation.

24-May
2019